Multifaceted Team-Based Intensive BP Control Effective in Low-Income Settings: NEJM
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2026-04-16 15:30 GMT | Update On 2026-04-16 15:30 GMT
USA: A protocol-based, team-driven hypertension management program was safe and effective among low-income patients in federally qualified health centers, as shown in the IMPACTS-BP trial. The intervention included intensive BP control protocols, audit and feedback, health coaching, and home monitoring. However, only 21.8% of patients achieved a systolic BP <120 mm Hg, possibly due to provider hesitancy without strong guideline endorsement.
The study published in the New England Journal of Medicine highlights the potential of structured, team-based approaches to improve blood pressure control in underserved populations. The trial addressed a critical gap, as individuals from low-income backgrounds continue to face a disproportionate burden of uncontrolled hypertension and its complications, yet evidence on scalable, real-world interventions has remained limited.
Led by Katherine T. Mills and colleagues, the IMPACTS-BP trial evaluated a multifaceted implementation strategy across federally qualified health centers in Louisiana and Mississippi. A total of 36 clinics were randomized to either the intervention or enhanced usual care. The intervention combined team-based care, standardized treatment protocols targeting intensive blood pressure reduction, regular audit and feedback mechanisms, lifestyle and medication adherence coaching, and home blood pressure monitoring. In contrast, the control group received physician education on hypertension management guidelines.
The study enrolled 1,272 adults aged 40 years or older with uncontrolled hypertension. The population largely represented vulnerable groups, with a mean age of 58.8 years; over half were women, nearly two-thirds were Black, and most participants had low income and were unemployed. These characteristics underscore the real-world relevance of the findings for high-risk communities.
The following were the key findings:
- A greater reduction in systolic blood pressure was observed in the intervention group compared to enhanced usual care after 18 months.
- Mean systolic BP decreased by 15.5 mm Hg in the intervention group versus 9.1 mm Hg in the control group, showing a significant between-group difference.
- Clinics using the multifaceted strategy showed better adherence to hypertension management practices, with higher adherence scores over time.
- The safety profile was comparable between groups, with similar rates of serious adverse events.
- Intensive, protocol-based blood pressure management did not increase patient risk.
- Despite improvements, only a modest proportion of patients achieved stricter blood pressure targets.
- These findings indicate potential barriers, such as clinician hesitancy in adopting intensive targets without strong guideline support.
Overall, the study provides robust evidence that a comprehensive, team-based approach can effectively reduce blood pressure among low-income patients in community health settings. The findings support broader implementation of such strategies to address persistent disparities in hypertension control, while also highlighting the need for continued efforts to optimize treatment targets and clinician engagement.
Reference:
DOI: 10.1056/NEJMoa2504068
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.